Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hepatic cirrhosis+1

Not yet recruiting

Registered drugNo placebo

Study of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Tinzaparin Sodium

Contact Research Centre

Hepatic cirrhosis

Not yet recruiting

Registered drugNo placebo

Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Hepatic cirrhosis

Not yet recruiting

Registered drug

Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Hepatic cirrhosis+2

Not recruiting

InvestigationalNo placebo

Study of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Citric Acid, Anhydrous Ph. Eur.

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Investigational

Study of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Resmetirom

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Safety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drug

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Hepatic cirrhosis+1

Not recruiting

Investigational

Study on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Galactoarabino-Rhamnogalacturonate

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Imiquimod

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Enoxaparin Sodium

Contact Research Centre

Hepatic cirrhosis+3

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hhalpc

Contact Research Centre

Find therapies in clinical trials near you – page 2

25 trials match your criteria

Hepatic cirrhosis+1

Study of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma

Hepatic cirrhosis

Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Hepatic cirrhosis

Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

Hepatic cirrhosis+2

Study of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications

Hepatic cirrhosis

Study of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health

Hepatic cirrhosis

Safety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis

Hepatic cirrhosis

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Hepatic cirrhosis

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Hepatic cirrhosis+1

Study on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis

Hepatic cirrhosis

Study on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination

Hepatic cirrhosis

Study on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome

Hepatic cirrhosis+3

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.